Silvia Stuedeli

Swiss Group For Clinical Cancer Research — Switzerland

Medicine · Health Sciences

1h-index13citations3works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(3), Cancer Treatment and Pharmacology(2), Cancer Research and Treatments(2), Cancer Genomics and Diagnostics(1), Cancer therapeutics and mechanisms(1)

Publications3 total

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
Investigational New Drugs·2019· 12 citedOpen Access
Phase 1/2a study of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors.
Journal of Clinical Oncology·2018· 1 cited
A phase I study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors.
Journal of Clinical Oncology·2017

Frequent Co-authors

Markus Joerger(3), Anastasios Stathis(3), Dagmar Hess(3), Marc Engelhardt(3), Patrice Larger(3), Heidi A. Lane(3), Nicole Lévy(3), Cristiana Sessa(3), Michael Mark(2), Thomas Kaindl(2), Peter Hafner(2), Roger von Moos(2), Ioannis Metaxas(2), Franziska Hutter(2), Michèle Landau-Salzberg(2), Phil McKernan(2), Yannis Metaxas(1), Mara Mantiero(1), Matthias Volden(1), Simona Berardi(1)